DE60035669D1 - Neue in einem hydrogel isolierte cochleat-formulierungen, verfahren zu deren herstellung und deren verwendung zur verabreichung von biologisch aktiven molekülen - Google Patents
Neue in einem hydrogel isolierte cochleat-formulierungen, verfahren zu deren herstellung und deren verwendung zur verabreichung von biologisch aktiven molekülenInfo
- Publication number
- DE60035669D1 DE60035669D1 DE60035669T DE60035669T DE60035669D1 DE 60035669 D1 DE60035669 D1 DE 60035669D1 DE 60035669 T DE60035669 T DE 60035669T DE 60035669 T DE60035669 T DE 60035669T DE 60035669 D1 DE60035669 D1 DE 60035669D1
- Authority
- DE
- Germany
- Prior art keywords
- hydrogel
- administration
- production
- biologically active
- active molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/829—Liposomes, e.g. encapsulation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/235,400 US6153217A (en) | 1999-01-22 | 1999-01-22 | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
US235400 | 1999-01-22 | ||
PCT/US2000/001684 WO2000042989A2 (en) | 1999-01-22 | 2000-01-24 | Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60035669D1 true DE60035669D1 (de) | 2007-09-06 |
DE60035669T2 DE60035669T2 (de) | 2008-02-07 |
Family
ID=22885334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60035669T Expired - Lifetime DE60035669T2 (de) | 1999-01-22 | 2000-01-24 | Neue in einem hydrogel isolierte cochleat-formulierungen, verfahren zu deren herstellung und deren verwendung zur verabreichung von biologisch aktiven molekülen |
Country Status (12)
Country | Link |
---|---|
US (7) | US6153217A (de) |
EP (1) | EP1143933B1 (de) |
JP (1) | JP2002535267A (de) |
AT (1) | ATE367800T1 (de) |
AU (1) | AU3213300A (de) |
CA (1) | CA2358505C (de) |
CY (1) | CY1106916T1 (de) |
DE (1) | DE60035669T2 (de) |
DK (1) | DK1143933T3 (de) |
ES (1) | ES2290019T3 (de) |
PT (1) | PT1143933E (de) |
WO (1) | WO2000042989A2 (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153217A (en) | 1999-01-22 | 2000-11-28 | Biodelivery Sciences, Inc. | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
WO2001052817A2 (en) * | 2000-01-24 | 2001-07-26 | Biodelivery Sciences, Inc. | Cochleate formulations and their use for delivering biologically relevant molecules |
DE10154464B4 (de) * | 2001-11-08 | 2005-10-20 | Max Delbrueck Centrum | Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol |
US20030219473A1 (en) * | 2002-03-26 | 2003-11-27 | Leila Zarif | Cochleates made with purified soy phosphatidylserine |
US20040092727A1 (en) * | 2002-11-13 | 2004-05-13 | Biopharm Solutions Inc. | Cochleates without metal cations as bridging agents |
CN1674869A (zh) * | 2002-08-06 | 2005-09-28 | 金拓 | 非金属阳离子作桥联剂的脂质卷 |
JP3927887B2 (ja) * | 2002-08-09 | 2007-06-13 | 本田技研工業株式会社 | 軸流圧縮機の静翼 |
US8685428B2 (en) * | 2002-12-10 | 2014-04-01 | Advanced Cardiovascular Systems, Inc. | Therapeutic composition and a method of coating implantable medical devices |
US8980310B2 (en) * | 2002-12-31 | 2015-03-17 | Bharat Serums and Vaccines, Ltd. | Non-pegylated long-circulating liposomes |
WO2004064805A1 (en) * | 2003-01-15 | 2004-08-05 | Biodelivery Sciences International, Inc. | Cochleate preparations of fragile nutrients |
US20050013854A1 (en) | 2003-04-09 | 2005-01-20 | Mannino Raphael J. | Novel encochleation methods, cochleates and methods of use |
JP4789208B2 (ja) | 2003-04-09 | 2011-10-12 | バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド | タンパク質発現に向けられた渦巻型組成物 |
DE10322439A1 (de) * | 2003-05-19 | 2004-12-09 | Bayer Ag | Verfahren und Vorrichtung zur Bestimmung der Isomerenzusammensetzung bei Isocyanat-Herstellprozessen |
SE527505C2 (sv) * | 2003-06-10 | 2006-03-28 | Anna Imberg | Komposita material och partiklar |
US20060188573A1 (en) * | 2003-06-10 | 2006-08-24 | Anna Imberg | Composite materials and particles |
EP1674093A4 (de) * | 2003-10-15 | 2009-12-09 | Nanoegg Res Lab Inc | Verfahren zur kontrolle der teilchengrösse von retinolsäure-nanoteilchen mit einer beschichtung aus polyvalentem anorganischem metallsalz und mit dem kontrollverfahren erhaltene nanoteilchen |
CN1859906A (zh) * | 2003-10-15 | 2006-11-08 | 株式会社纳米卵 | 含有多价金属无机盐包覆的视黄酸纳米颗粒的组合物 |
WO2005063213A1 (en) * | 2003-12-19 | 2005-07-14 | Biodelivery Sciences International, Inc. | Rigid liposomal cochleate and methods of use and manufacture |
US20050244522A1 (en) * | 2004-04-30 | 2005-11-03 | Carrara Dario Norberto R | Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents |
US7494526B2 (en) * | 2004-07-14 | 2009-02-24 | Yavitz Edward Q | Plant protection and growth stimulation by nanoscalar particle folial delivery |
US20060040896A1 (en) * | 2004-08-18 | 2006-02-23 | Paringenix, Inc. | Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity |
US20070082115A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William Ronald Jr | Methods for inducing satiety, reducing food intake and reducing weight |
US20070082030A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William R | Fiber satiety compositions |
US20070082107A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William R Jr | Compositions and methods for reducing food intake and controlling weight |
US20070082029A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William R | Fiber satiety compositions |
WO2008024389A2 (en) * | 2006-08-23 | 2008-02-28 | Biodelivery Sciences International, Inc. | Amphiphilic nucleotide cochleate compositions and methods of using the same |
US20080085354A1 (en) * | 2006-10-06 | 2008-04-10 | Teresa Marie Paeschke | Controlled hydration of hydrocolloids |
CA2672338C (en) | 2006-12-15 | 2017-06-06 | National Research Council Of Canada | Archaeal polar lipid aggregates for administration to animals |
US20090054374A1 (en) * | 2007-02-28 | 2009-02-26 | Paringenix, Inc. | Methods of treating acute exacerbations of chronic obstructive pulmonary disease |
US8591225B2 (en) * | 2008-12-12 | 2013-11-26 | Align Technology, Inc. | Tooth movement measurement by automatic impression matching |
CA2694189A1 (en) * | 2007-07-23 | 2009-01-29 | University Of Utah Research Foundation | Method for blocking ligation of the receptor for advanced glycation end-products (rage) |
US20090047336A1 (en) * | 2007-08-17 | 2009-02-19 | Hong Kong Baptist University | novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
JP2010539245A (ja) | 2007-09-14 | 2010-12-16 | 日東電工株式会社 | 薬物担体 |
ES2630805T3 (es) | 2008-07-14 | 2017-08-24 | Polypid Ltd. | Composición de vehículo de fármaco de liberación sostenida |
US20100113352A1 (en) | 2008-11-06 | 2010-05-06 | Elliott Millstein | Retinol formulations and methods for their use |
IN2012DN00570A (de) | 2009-07-14 | 2015-06-12 | Polypid Ltd | |
WO2011016043A2 (en) | 2009-08-06 | 2011-02-10 | Technion Research & Development Foundation Ltd. | Antibiotic drug delivery and potentiation |
WO2011031018A2 (ko) * | 2009-09-14 | 2011-03-17 | 한남대학교 산학협력단 | 서방형 방출이 가능한 수용성 약물 전달 시스템 |
WO2011089595A2 (en) * | 2010-01-19 | 2011-07-28 | Polypid Ltd. | Sustained-release nucleic acid matrix compositions |
EP2533762B1 (de) * | 2010-02-10 | 2019-03-27 | Biopelle Inc. | Retinolformulierungen und verfahren zu ihrer verwendung |
CN113018452A (zh) | 2011-04-29 | 2021-06-25 | 西莱克塔生物科技公司 | 用于效应性t细胞的抗原特异性缺失的致耐受性合成纳米载体 |
ES2741282T3 (es) * | 2011-05-05 | 2020-02-10 | Matinas Biopharma Nanotechnologies Inc | Composiciones de cocleato y métodos de elaboración y uso de las mismas |
AU2012278832B2 (en) | 2011-07-06 | 2017-04-20 | The Regents Of The University Of California | Multiple-enzyme nanocomplexes |
WO2013033717A1 (en) | 2011-09-02 | 2013-03-07 | The Regents Of The University Of California | Enzyme responsive nanocapsules for protein delivery |
LT2846809T (lt) | 2012-05-09 | 2021-01-25 | Cantex Pharmaceuticals, Inc. | Mielosupresijos gydymas |
WO2014151775A1 (en) * | 2013-03-15 | 2014-09-25 | Robert Bosch Gmbh | Heated garment and battery holster |
CA2910575C (en) * | 2013-05-03 | 2023-10-24 | Selecta Biosciences, Inc. | Tolerogenic synthetic nanocarriers and therapeutic macromolecules for reduced or enhanced pharmacodynamic effects |
US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
EP3258941A4 (de) | 2015-02-17 | 2018-09-26 | Cantex Pharmaceuticals, Inc. | Behandlung von durch cxcl12-cxcr4 interaktion privilegierten krebs- und hämatopoetischen stammzellerkrankungen |
AU2016226151B2 (en) | 2015-03-03 | 2021-02-25 | Matinas Biopharma Nanotechnologies, Inc. | Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent |
AU2016352874B2 (en) * | 2015-11-10 | 2021-06-24 | Children's Research Institute, Children's National Medical Center | Echinomycin formulation, method of making and method of use thereof |
JP6991592B2 (ja) * | 2016-07-12 | 2022-01-12 | マティナス バイオファーマ ナノテクノロジーズ,インコーポレーテッド | 中枢神経系送達のためのコクリエート化抗真菌化合物及びクリプトコッカス感染症の治療 |
KR101989789B1 (ko) | 2017-11-30 | 2019-06-18 | (주) 에이치엔에이파마켐 | 포스파티딜세린/음이온계면활성제/염화칼슘을 이용한 코킬레이트 |
WO2020066471A1 (ja) * | 2018-09-28 | 2020-04-02 | 株式会社マンダム | 化粧料 |
US20220226465A1 (en) | 2021-01-18 | 2022-07-21 | ConserV Bioscience | Coronavirus Immunogenic Compositions, Methods and Uses Thereof |
WO2024039733A1 (en) | 2022-08-16 | 2024-02-22 | Matinas Biopharma Nanotechnologies, Inc. | Methods of controlling lipid nanocrystal particle size and lipid nanocrystals produced by such methods |
WO2024039729A1 (en) | 2022-08-16 | 2024-02-22 | Matinas Biopharma Nanotechnologies, Inc. | Antifungal agent encapsulated in a lipid nanocrystal for treating mucormycosis |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663161A (en) * | 1985-04-22 | 1987-05-05 | Mannino Raphael J | Liposome methods and compositions |
US4871488A (en) * | 1985-04-22 | 1989-10-03 | Albany Medical College Of Union University | Reconstituting viral glycoproteins into large phospholipid vesicles |
US4990291A (en) * | 1986-04-15 | 1991-02-05 | The United States Of America As Represented By The Secretary Of The Navy | Method of making lipid tubules by a cooling process |
US5269979A (en) * | 1988-06-08 | 1993-12-14 | Fountain Pharmaceuticals, Inc. | Method for making solvent dilution microcarriers |
AU638271B2 (en) * | 1989-06-22 | 1993-06-24 | Nexstar Pharmaceuticals, Inc. | Encapsulation process |
US5994318A (en) * | 1993-10-04 | 1999-11-30 | Albany Medical College | Cochleate delivery vehicles |
US5643574A (en) * | 1993-10-04 | 1997-07-01 | Albany Medical College | Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
US5840707A (en) * | 1993-10-04 | 1998-11-24 | Albany Medical College | Stabilizing and delivery means of biological molecules |
CA2246754C (en) | 1996-02-22 | 2002-10-22 | Raphael James Mannino | Cochleate delivery vehicles |
US6120751A (en) * | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
US6153217A (en) | 1999-01-22 | 2000-11-28 | Biodelivery Sciences, Inc. | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
-
1999
- 1999-01-22 US US09/235,400 patent/US6153217A/en not_active Expired - Fee Related
-
2000
- 2000-01-24 CA CA2358505A patent/CA2358505C/en not_active Expired - Fee Related
- 2000-01-24 AT AT00909961T patent/ATE367800T1/de active
- 2000-01-24 JP JP2000594446A patent/JP2002535267A/ja active Pending
- 2000-01-24 ES ES00909961T patent/ES2290019T3/es not_active Expired - Lifetime
- 2000-01-24 PT PT00909961T patent/PT1143933E/pt unknown
- 2000-01-24 DK DK00909961T patent/DK1143933T3/da active
- 2000-01-24 AU AU32133/00A patent/AU3213300A/en not_active Abandoned
- 2000-01-24 WO PCT/US2000/001684 patent/WO2000042989A2/en active IP Right Grant
- 2000-01-24 EP EP00909961A patent/EP1143933B1/de not_active Expired - Lifetime
- 2000-01-24 DE DE60035669T patent/DE60035669T2/de not_active Expired - Lifetime
- 2000-07-11 US US09/613,840 patent/US6592894B1/en not_active Expired - Lifetime
-
2003
- 2003-04-23 US US10/421,358 patent/US20030228355A1/en not_active Abandoned
-
2005
- 2005-01-18 US US11/040,615 patent/US20050186265A1/en not_active Abandoned
-
2007
- 2007-10-08 CY CY20071101285T patent/CY1106916T1/el unknown
-
2008
- 2008-04-23 US US12/148,942 patent/US20090028904A1/en not_active Abandoned
-
2012
- 2012-04-06 US US13/441,030 patent/US20120294901A1/en not_active Abandoned
-
2013
- 2013-12-31 US US14/145,268 patent/US20140220109A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2290019T3 (es) | 2008-02-16 |
US20140220109A1 (en) | 2014-08-07 |
US20050186265A1 (en) | 2005-08-25 |
WO2000042989A2 (en) | 2000-07-27 |
US6592894B1 (en) | 2003-07-15 |
US20090028904A1 (en) | 2009-01-29 |
JP2002535267A (ja) | 2002-10-22 |
ATE367800T1 (de) | 2007-08-15 |
US6153217A (en) | 2000-11-28 |
AU3213300A (en) | 2000-08-07 |
US20030228355A1 (en) | 2003-12-11 |
EP1143933A2 (de) | 2001-10-17 |
CA2358505A1 (en) | 2000-07-27 |
US20120294901A1 (en) | 2012-11-22 |
EP1143933B1 (de) | 2007-07-25 |
WO2000042989A3 (en) | 2000-11-30 |
DE60035669T2 (de) | 2008-02-07 |
CY1106916T1 (el) | 2012-09-26 |
CA2358505C (en) | 2010-04-06 |
PT1143933E (pt) | 2007-09-03 |
DK1143933T3 (da) | 2007-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60035669D1 (de) | Neue in einem hydrogel isolierte cochleat-formulierungen, verfahren zu deren herstellung und deren verwendung zur verabreichung von biologisch aktiven molekülen | |
Wang et al. | An enzyme‐responsive polymeric superamphiphile | |
Matos et al. | Alternating current electric field effects on neural stem cell viability and differentiation | |
DE69630691T2 (de) | Liposomal p-Ethoxy Oligonucleotides | |
ATE66947T1 (de) | Verfahren zur herstellung von kleinen, sphaerischen polymerpartikeln. | |
US10485827B2 (en) | Topical eye serum compositions, methods or preparing, and methods of use | |
DE69102062T2 (de) | Immobilisierte polyethylenoxyd-sternmoleküle für bioanwendungen. | |
ATE204469T1 (de) | Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln | |
DE69913685T2 (de) | Verfahren zur mikroverkapselung und elektrostatische behandlung | |
ES2119250T3 (es) | Composiciones y metodos para estimular el crecimiento y diferenciacion de megacariocitos. | |
ATE180408T1 (de) | Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen | |
WO2001052817A3 (en) | Cochleate formulations and their use for delivering biologically relevant molecules | |
EP0281679A2 (de) | Niedermolekulare Alkalihuminate, Verfahren zur ihrer Herstellung und Verwendung | |
DE3209098A1 (de) | Verfahren zur kultivierung verankerungsabhaengiger zellen | |
Kawakami et al. | Liver plasma membranes and proteoglycan prepared therefrom inhibit the growth of hepatoma cells in vitro | |
ATE242816T1 (de) | Verfahren zur reinigung von hyaluronsäure mit hohem molekulargewicht | |
DE69911614D1 (de) | Komponenten mit niedrigem molekulargewicht aus knorpelgewebe von haien, verfahren zur herstellung und therapeutische verwendungen | |
Xu et al. | Solution–air interface synthesis and growth mechanism of tooth enamel-like hydroxyapatite/chondroitin sulfate films | |
DE69427234T2 (de) | Verfahren zur herstellung von hochtransformierbaren bakterienzellen und dadurch herggestellte zellen | |
Svarnas et al. | Liposomal membrane disruption by means of miniaturized dielectric-barrier discharge in air: liposome characterization | |
DE50107344D1 (de) | Herstellung von polygalakturoniden und ihre verwendung als lebensmittelzusatzstoffe | |
Santos‐Ebinuma et al. | Extraction of natural red colorants from the fermented broth of Penicillium purpurogenum using aqueous two‐phase polymer systems | |
ATE92075T1 (de) | Verfahren zur gewinnung aktiver proteine aus einer biologisch inaktiven form. | |
Schuster et al. | From fibers to micelles using point-mutated amphiphilic peptides | |
EP0537429B1 (de) | Modifizierte Huminate, Verfahren zu ihrer Herstellung und Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8381 | Inventor (new situation) |
Inventor name: ZARIF, LEILA, NEWARK, NJ 07103-3000, US Inventor name: JIN, TUO, NEWARK, NJ 07103-3000, US Inventor name: SEGARRA, IGNACIO, NEWARK, NJ 07103-3000, US Inventor name: MANNINO, RAPHAEL, NEWARK NJ 07103-3000, US |
|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803 |